Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

The therapeutic programs of 23andMe include an antibody that restores the ability of the immune system to kill cancer cells.

DNA-testing company 23andMe Holding Co. will slash its workforce by about 40% and discontinue its therapeutics program as ...

Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing ...

DNA-testing company 23andMe said on Monday that it was firing roughly 40% of its workforce, more than 200 people, as Chief ...

Me's big push into drug development, announced with great fanfare almost a decade ago, has ended with a whimper and sweeping ...

The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.

23andMe is shutting down its therapeutics development division, and plans to seek out buyers to find a new home for its ...

23andMe, a leading name in the genetic testing business, has revealed plans to lay off some 200 employees, or nearly 40% of ...

Me is closing its therapeutics division and will wind down ongoing clinical trials, the struggling genetic testing company ...

23andMe ME2.90%increase; green up pointing triangle is further streamlining its operations as it discontinues its pipeline of ...

(Reuters) - Genetic testing firm 23andMe said on Monday it is reducing its overall headcount by over 200 employees or about ...